Two Sigma Advisers’s Seres Therapeutics MCRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-985
| Closed | -$110K | – | 2680 |
|
|
2022
Q4 | $110K | Sell |
985
-4,715
| -83% | -$528K | ﹤0.01% | 2280 |
|
|
2022
Q3 | $732K | Sell |
5,700
-8,335
| -59% | -$1.07M | ﹤0.01% | 1682 |
|
|
2022
Q2 | $963K | Sell |
14,035
-100
| -0.7% | -$6.86K | ﹤0.01% | 1615 |
|
|
2022
Q1 | $2.01M | Buy |
14,135
+1,840
| +15% | +$262K | 0.01% | 1249 |
|
|
2021
Q4 | $2.05M | Sell |
12,295
-14,550
| -54% | -$2.42M | 0.01% | 1193 |
|
|
2021
Q3 | $3.74M | Buy |
26,845
+25,155
| +1,488% | +$3.5M | 0.01% | 930 |
|
|
2021
Q2 | $806K | Sell |
1,690
-4,270
| -72% | -$2.04M | ﹤0.01% | 1730 |
|
|
2021
Q1 | $2.45M | Buy |
5,960
+3,645
| +157% | +$1.5M | 0.01% | 1171 |
|
|
2020
Q4 | $1.13M | Buy |
2,315
+635
| +38% | +$311K | ﹤0.01% | 1507 |
|
|
2020
Q3 | $951K | Sell |
1,680
-4,165
| -71% | -$2.36M | ﹤0.01% | 1521 |
|
|
2020
Q2 | $556K | Buy |
5,845
+1,380
| +31% | +$131K | ﹤0.01% | 1849 |
|
|
2020
Q1 | $319K | Buy |
4,465
+585
| +15% | +$41.8K | ﹤0.01% | 1988 |
|
|
2019
Q4 | $268K | Buy |
3,880
+730
| +23% | +$50.4K | ﹤0.01% | 2098 |
|
|
2019
Q3 | $253K | Buy |
3,150
+810
| +35% | +$65.1K | ﹤0.01% | 1978 |
|
|
2019
Q2 | $151K | Buy |
2,340
+1,180
| +102% | +$76.1K | ﹤0.01% | 2170 |
|
|
2019
Q1 | $159K | Buy |
1,160
+300
| +35% | +$41.1K | ﹤0.01% | 2147 |
|
|
2018
Q4 | $78K | Sell |
860
-80
| -9% | -$7.26K | ﹤0.01% | 2240 |
|
|
2018
Q3 | $143K | Sell |
940
-125
| -12% | -$19K | ﹤0.01% | 2123 |
|
|
2018
Q2 | $183K | Buy |
1,065
+190
| +22% | +$32.6K | ﹤0.01% | 2214 |
|
|
2018
Q1 | $128K | Sell |
875
-900
| -51% | -$132K | ﹤0.01% | 2202 |
|
|
2017
Q4 | $360K | Buy |
1,775
+1,075
| +154% | +$218K | ﹤0.01% | 1884 |
|
|
2017
Q3 | $225K | Buy |
700
+190
| +37% | +$61.1K | ﹤0.01% | 2022 |
|
|
2017
Q2 | $115K | Hold |
510
| – | – | ﹤0.01% | 2171 |
|
|
2017
Q1 | $115K | Buy |
510
+10
| +2% | +$2.26K | ﹤0.01% | 2266 |
|
|
2016
Q4 | $99K | Buy |
+500
| New | +$99K | ﹤0.01% | 2267 |
|